That said, its not a shortcut
Other recognised effects include injection site reactions, and rarely, acute pancreatitis, gallbladder disease, or diabetic retinopathy complications with rapid glucose improvement
Across GLP-1 medications, the same three injection sites are recommended: your abdomen, the front or outer part of your thigh, and the back of your upper arm
"Once the drug is negotiated, it must be featured on formulary in Medicare
Back Lau, J, Bloch, K, Schffer, L, et al (24 Sept 2015) 'Discovery of the once-weekly glucagon-like peptide-1 (glp-1) analogue Semaglutide', Journal Medicinal Chemistry , 58/18